CLRB reverse split history: Cellectar Biosciences INC NEW
Listed on Nasdaq. Split dates, ratios and the filings behind them.
Split history
| Effective date | Direction | Ratio | Status |
|---|---|---|---|
| Jun 24, 2025 | Reverse | 1 to 30 | Took effect |
| Jul 22, 2022 | Reverse | 1 to 10 | Took effect |
| Jul 17, 2018 | Reverse | 1 to 10 | Took effect |
| Mar 7, 2016 | Reverse | 1 to 10 | Took effect |
| Jun 16, 2014 | Reverse | 1 to 20 | Took effect |
| Jun 13, 2005 | Forward | 4 to 1 | Took effect |
Exchange listing context
No exchange deficiency notice found for CLRB in the index.
Exchange deficiency notices Signal8 detected in 8-K Item 3.01 filings. No notice listed means none was found in that index, not that the company is in compliance.
Approval timeline
LockedEvery filing and step from proposal to effective date. Nothing to show for this ticker yet.
Included with SplitScanner ($9.99 a month) and Signal8 Pro.
Unlock with SplitScannerHow it traded after each split
Locked5 executed reverse splits on record. The move over the 30 days after each one, on one split basis.
Included with SplitScanner ($9.99 a month) and Signal8 Pro.
Unlock with SplitScannerFloat before and after
Locked76 float samples on record. Float around each split, from the daily float record.
Included with SplitScanner ($9.99 a month) and Signal8 Pro.
Unlock with SplitScannerAI summaries of the filings
LockedPlain-English readings of each filing and press release about the split, from the Signal8 analysis. Nothing to show for this ticker yet.
Included with SplitScanner ($9.99 a month) and Signal8 Pro.
Unlock with SplitScannerSplit dates and ratios come from the market split calendar and are cross-checked against a second source; a row only one source evidences is marked unconfirmed. Funds, ETFs and other non-equity securities are excluded. The index is keyed by ticker symbol, so a company that changed symbol between splits appears under each symbol.